Select a category
Fatima Dangote has said that Nigeria would be a better place if there were a few more men like her father, Aliko Dangote.
Fatima, who spoke at a media session hosted at the Dangote Petroleum Refinery in Ibeju-Lekki, Lagos State, lauded her father’s steadfast pursuit of the Nigerian dream.
She expressed admiration for his resilience and echoed a wish for more visionary leaders like him in the country, believing their collective efforts could significantly enhance Nigeria’s future.
“I have not seen anyone as hardworking as my father, sometimes I wonder how he never gives up. I wish we have a few more men like my father in Nigeria, the country will be a better place,” she said.
A Nigerian man has reacted to a picture of a building erected on the railway line.
He said now, if the government wakes up tomorrow and start demolishing, they will set the camera and cry that the government took their house
Influencer Pamilerin has revealed that buying of food outside is now cheaper than cooking at home.
He said I think Buying food outside is now cheaper than cooking at home.
Edo State Unites Against Political Violence: Justice for Monday Okpebholo
After a slight dip Thursday, bitcoin (BTC) gained roughly 4% in Friday trading and is back above $66,000.
It was another positive day for U.S. spot bitcoin exchange-traded funds (ETFs) on Thursday, as $84.8 million flowed into these products, according to Farside Investors. This takes the week's total inflows to $861.5 million so far.
Optimism around the approval and potential trading debut next week of spot ether ETFs is also growing, pushing ether (ETH) prices higher. Issuers of these products have unveiled their fee structure and now await a final nod from the Securities and Exchange Commission (SEC). The native token of the Ethereum blockchain was also up around 2% in Friday trading.
Outside of the two largest crypto tokens by market cap, XRP has been performing relatively well lately, with the alternative crypto asset up nearly 10% over the week.
XRP has been performing particularly well in South Korea, where the digital asset accounted for 35% to 40% of all trading volume on three popular crypto exchanges there from Tuesday through Thursday, reported. Price speculation for XRP, used by blockchain technology firm Ripple to facilitate transactions, has increased ahead of a potential resolution to Ripple's legal battle with the SEC over whether XRP is an unregistered security. Earlier this week, Ripple CEO Brad Garlinghouse told , "We expect resolution very soon."
In addition, as one of the projects targeted by the SEC with an enforcement action, some market observers expect XRP to benefit from a potential victory of a pro-crypto Donald Trump in the U.S. presidential elections.
Do you have a news tip for Investopedia reporters? Please email us at tips@investopedia.comRead more on Investopedia
Eli Lilly and Co. (LLY) announced on its WeChat account Friday that it has won approval from Chinese regulators to sell tirzepatide for weight loss in the country.
Tirzepatide is the active ingredient in Lilly’s injectable diabetes drug Mounjaro and weight-loss drug Zepbound. Mounjaro previously was approved in China for diabetes treatment.
The approval comes after Danish rival Novo Nordisk (NVO) announced in June that its weight-loss drug Wegovy received similar approval in China. Last week, a JAMA Internal Medicine study found that tirzepatide caused greater weight loss than semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy.
Competition between the drugmakers in the world’s second-largest economy will be crucial, with the global weight-loss market expected to reach $77 billion annually by 2030, according Morgan Stanley analysts.
Eli Lilly did not specify when sales of the drug would begin in China, or how many doses would be sold, according to . The drugmaker did not immediately respond to 's request for comment.
Eli Lilly shares rose 1.4% to $860.50 as of 1 p.m. ET Friday and are up almost 50% year-to-date. Novo Nordisk American depositary receipts (ADRs) were up 1.7% to $132.19 and have added about 28% in 2024.
Do you have a news tip for Investopedia reporters? Please email us at tips@investopedia.comRead more on Investopedia